Nodular nonpurulent panniculitis is a rare inflammatory disease characterized by the formation of painful, dense nodules under the skin, usually on the extremities and trunk. This pathology refers to benign inflammation of the subcutaneous tissue and can manifest itself in the form of single or multiple nodules. The clinical picture includes pain, swelling, and sometimes erythematous changes in the skin. Nodular nonpurulent panniculitis can be associated with various systemic diseases, infections, and even with certain drugs. Data on the pathogenesis of the disease remain limited, which makes diagnosis and therapy difficult.
History of the disease and interesting historical facts
Nodular non-suppurative panniculitis was first described in the early 20th century, but its symptoms and etiology remained unclear for a long time. Initially, the condition was perceived as a rare form of dermatosis. In the medical literature of the first descriptions, cases were associated with concomitant infections, such as tuberculosis, which was consistent with the ideas of the time about the relationship between infection and dermatological manifestations. In the following decades, other possible associated conditions were identified, such as vasculitis and systemic connective tissue diseases. Modern research has begun to identify the molecular mechanisms responsible for the development of the disease.
Epidemiology
The epidemiology of nodular non-suppurative panniculitis remains poorly understood. Cases have been documented in both men and women in clinical studies, with a suggestion of a greater predisposition in women. The prevalence of the condition varies considerably by geographic region and may be as low as 0.1 to 1 case per 1000 population. Incidence data primarily come from clinics where cases with confirmed diagnosis are recorded, which may highlight the underreporting of asymptomatic forms or cases identified in primary care settings.
Genetic predisposition to this disease
Genetic predisposition to nodular non-purulent panniculitis is poorly understood, but some studies suggest that specific genes associated with the immune response may be involved in the development of the disease. In particular, polymorphisms in genes responsible for the production of cytokines such as IL-6 and IL-1β may be involved. Initial data also support the involvement of genes associated with inflammatory processes such as TNF-α. It is assumed that numerous mutations in these genes may aggravate inflammatory reactions in the subcutaneous tissue, contributing to the formation of nodules.
Risk factors for the development of this disease
Risk factors for nodular non-purulent panniculitis are divided into physical and chemical. These include:
- Physical factors: overexertion and skin trauma, especially in the subcutaneous tissue area;
- Chemical factors: exposure to certain chemicals and drugs, such as some antibiotics and anti-inflammatory drugs;
- Systemic diseases: presence of pre-existing diseases, including diabetes, thyroid disease and HIV infection;
- Infections: concomitant microbial or viral infections.
Thus, a comprehensive analysis of risk factors allows for a more accurate prediction of the possibility of developing nodular non-purulent panniculitis.
Diagnosis of this disease
Diagnosis of nodular non-purulent panniculitis requires a comprehensive approach and includes both visual examination and laboratory and radiological studies. The main symptoms that are paid attention to are the presence of painful nodules, changes in skin color and local swelling. Laboratory studies may include:
- General blood test: to assess the presence of an inflammatory process;
- Biochemical analysis: to determine the level of acute phase proteins;
- Immunological tests: to identify possible autoimmune markers.
Radiological examinations are not routine but may be used to assess the depth of the lesion. Other diagnostic tests include skin biopsy, which may aid in the differential diagnosis with other forms of panniculitis. The differential diagnosis also includes ruling out systemic diseases and infections.
Treatment
Treatment of nodular non-purulent panniculitis includes both general and specific approaches. General treatment may consist of:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief;
- Corticosteroids to reduce inflammation in severe cases;
- Immunosuppressive agents in cases associated with autoimmune diseases.
Pharmacological treatment may require an individual approach based on the clinical symptom pattern. Surgical treatment is rarely used but may be necessary if abscesses or tissue necrosis occur. Other treatments may include physical therapy and alternative methods such as laser therapy to reduce pain and improve skin appearance.
List of medications used to treat this disease
The main groups of drugs used to treat nodular non-purulent panniculitis include:
- Nonsteroidal anti-inflammatory drugs (Ibuprofen, Naproxen);
- Corticosteroids (Prednisolone);
- Immunosuppressants (Methotrexate, Azathioprine);
- Antibiotics (for secondary infection);
- Gels and creams containing steroids.
Prescribing medications should only be done by a qualified physician after a complete diagnosis.
Disease monitoring
Monitoring of nodular non-purulent panniculitis includes regular control stages to assess the dynamics of the patient's condition. The prognosis with early detection and adequate treatment is usually favorable. Complications may include secondary infections, as well as changes in quality of life due to pain syndrome and cosmetic defects.
Age-related features of the disease
Nodular non-purulent panniculitis can manifest itself at any age, but its primary cases are more often observed in young and middle-aged people. In childhood, the disease may proceed more mildly, while in older patients, more pronounced inflammatory reactions and, possibly, longer remissions are observed. Also, in older age, a high level of concomitant diseases may be observed, which aggravates the clinical picture of the disease.
Questions and Answers
- What are the main symptoms of nodular non-purulent panniculitis? The main symptoms include painful nodules on the skin, possible redness and swelling in the affected area, and general weakness and malaise.
- What diagnostic methods are used to confirm the diagnosis? The main diagnostic methods include a visual examination, laboratory blood tests, and a biopsy, which helps rule out other diseases.
- What are the treatments for nodular non-purulent panniculitis? Treatment may range from anti-inflammatory drugs to corticosteroids and immunosuppressants in severe cases.
- Is there a risk of recurrence of the disease? Yes, nodular non-purulent panniculitis can have a recurrent course, especially in the presence of predisposing factors.
- Can nodular non-suppurative panniculitis affect overall health? In most cases, the disease is not life-threatening, but can significantly worsen the quality of life due to pain and cosmetic defects.
